News

The Codex Committee on Food Labelling is reviewing provisions relevant to allergen labelling in the General Standard for the Labelling of Packaged Foods (GSLPF), as well as developing guidance on the use of precautionary allergen or advisory labelling (PAL). In…

Stakeholders in England, Wales and Northern Ireland are being invited to comment on the updated Food Standards Agency (FSA) Technical Guidance on food allergen labelling and information requirements. The updates reflect changes to allergen labelling legislation in England which comes…

Peanut allergy is the leading cause of fatal food-related anaphylaxis, but not everyone with peanut allergy is at risk of a severe response. New work conducted at the Mount Sinai School of Medicine has pin-pointed novel genes associated with the…

Most people with peanut allergy are not allergic to tree nuts, but new research has shown that over 30 per cent will avoid all tree nuts. A number of reasons were proffered by those who avoid tree nuts, the most…

The Allergen Bureau was pleased to welcome 10 new small to medium enterprises as Associate Members: Category A, B or C in our 2019 membership year. Allergen Bureau Associate Memberships provide an effective way for organisations of less than 100…

By the end of January 2020, the FDA will have announced its decision regarding approval of the Aimmune Therapeutics peanut allergy drug Palforzia (AR101). The company recently presented information about their new drug, and others they have in the pipeline,…